Market Overview

UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Insulet Corporation

Share:
Related PODD
Oppenheimer Reiterates Rating, Lowers Price Target On Insulet As New Management Begins Executing Plan
Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

In a report published Friday, Canaccord Genuity reiterated its Buy rating on Insulet Corporation (NASDAQ: PODD), and raised its price target from $24.50 to $29.00.

Canaccord Genuity noted, “We are reiterating our BUY rating on Insulet and naming it one of our top growth picks for 2013. We believe a new product cycle could not only drive accelerating revenue growth, but also result in significant improvements in operating results. Furthermore, already operating cash flow positive in Q4/12, we believe the company is well positioned to become FCF positive in 2013 and EPS positive in 2014.”

Insulet Corporation closed on Thursday at $21.23.

Latest Ratings for PODD

DateFirmActionFromTo
Jan 2015Leerink SwannMaintainsOutperform
Jan 2015JP MorganDowngradesOverweightNeutral
Jan 2015JefferiesMaintainsBuy

View More Analyst Ratings for PODD
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Price Target Analyst Ratings

 

Related Articles (PODD)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional